Financials in USD. Standardized financial statements.
A compact view of how Vitamin Blue, Inc. turns revenue into operating income and net income.
| Metric | FY 2017 | FY 2016 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|---|
| Revenue? | $250,027 | $217,211 | $129,652 | $104,998 | $112,947 | $131,817 | $129,256 |
| Revenue Growth? | +15.1% | +67.5% | +23.5% | -7.0% | -14.3% | +2.0% | 0.0% |
| Cost of Revenue? | $153,520 | $129,979 | $74,153 | $73,303 | $85,581 | $100,478 | $99,508 |
| Gross Profit? | $96,507 | $87,232 | $55,499 | $31,695 | $27,366 | $31,339 | $29,748 |
| Gross Margin? | +38.6% | +40.2% | +42.8% | +30.2% | +24.2% | +23.8% | +23.0% |
| Operating Expenses? | $130,828 | $119,445 | $174,637 | $159,812 | $122,447 | $127,837 | $102,050 |
| Operating Income? | -$34,321 | -$32,210 | -$119,138 | -$128,117 | -$95,081 | -$96,498 | -$72,302 |
| EBITDA? | -$2,852 | -$54,073 | -$10,308 | -$134,759 | -$101,605 | -$95,596 | -$70,136 |
| Income Before Tax | -$21,077 | -$87,851 | -$107,026 | -$223,678 | -$157,948 | -$108,477 | -$82,258 |
| Income Tax Expense | $0 | $11 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$21,077 | -$87,851 | -$107,026 | -$223,678 | -$157,948 | -$108,477 | -$82,258 |
| EPS? | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
| Diluted EPS? | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality